Organogenesis Investor Relations Material

Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacturing, and commercialization of products for the advanced wound care and surgical biologics markets. The company's portfolio includes skin substitutes and other tissue-based products designed to promote healing and tissue regeneration. Organogenesis serves healthcare providers, offering solutions for the treatment of chronic and acute wounds, as well as products used in surgical and sports medicine applications. The company is headquartered in Canton, Massachusetts, and its shares are listed on the NASDAQ.